Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2006
01/26/2006US20060019294 Tyrosine kinase substrate (Tks) proteins
01/26/2006US20060019293 Mutations of the 5' region of the human 5-HT1A gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses
01/26/2006US20060019287 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/26/2006US20060019285 Analysis of intracellular modifications
01/26/2006US20060019279 Methods for target molecule detection using siderophores and related compositions
01/26/2006US20060019275 Nucleic acids encoding proteins involved in sensory transduction
01/26/2006US20060019271 Submergence-induced protein-like factors
01/26/2006US20060019265 Transmission-based luminescent detection systems
01/26/2006US20060019261 RNA-binding protein
01/26/2006US20060019256 Compositions and methods for treating and diagnosing cancer
01/26/2006US20060019252 Genes and polypeptides relating to hepatocellular or colorectal carcinoma
01/26/2006US20060019249 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor-and non-tumor cells
01/26/2006US20060019244 Sensor element comprising recognition ligands bound to a film on a single mode planar optical waveguide, film consisting of a membrane, a polymerized bilayer membrane, and a self-assembled monolayer containing polyethylene glycol or polypropylene glycol groups therein; detecting and quantifying proteins
01/26/2006US20060019243 Method and device for mixing samples on a support
01/26/2006US20060019241 Na+ and CI-coupled transport system for endogenous opioid peptides
01/26/2006US20060019240 Posh nucleic acids, polypeptides and related methods
01/26/2006US20060019238 Method for identifying protein-protein interactions
01/26/2006US20060019236 Membrane fusion assay
01/26/2006US20060018932 Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1
01/26/2006US20060018920 Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
01/26/2006US20060018918 Production of stabilized conformational isomers of disease associated proteins
01/26/2006US20060018917 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
01/26/2006US20060018914 Novel antibody conjugates reactive with human carcinomas
01/26/2006US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
01/26/2006US20060018893 Method for determining modulation of P110delta activity
01/26/2006US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
01/26/2006US20060018873 inducing in a patient, at least one activity of IL-2 selected from increasing humoral immune responses and increasing cellular immune responses, by administering to said patient a therapeutically effective amount of a peptide sufficient to induce the activity
01/26/2006US20060018836 Method for treating human tumor cells with a newcastle disease virus strain having a p53 independent oncolytic effect
01/26/2006US20060018833 Method and system for screening compounds for muscular and/or neurological activity in animals
01/26/2006US20060018798 Liquid filtering instrument and dry type analysis device
01/26/2006US20060018793 Method of measuring formaldehyde concentration of gas and measuring instrument
01/26/2006US20060016996 Device for identifying types of sheet materials
01/26/2006US20060016701 Point of care heparin determination system
01/26/2006US20060016700 Transcutaneous analyte sensor
01/26/2006US20060016699 Apparatus and method for measuring biological material
01/26/2006US20060016698 Method and apparatus for electrochemical detection
01/26/2006US20060016686 Blood glucose meter
01/26/2006US20060016250 Techniques for dynamically testing and evaluating materials and coatings in moving solutions
01/26/2006US20060016244 Engagement of a sensor system with a vehicle operating device
01/26/2006DE50006083C5 Labormässige untersuchung einer körperflüssigkeits- oder gewebeprobe Labware examination of a body fluid or tissue sample
01/26/2006DE202005017486U1 Fluid filterability testing device, especially for gear oils, has test filter arrangement and circulation circuit that also incorporates foam tester which monitors fluid foam formation during its cycling through filter
01/26/2006DE202004014397U1 Flue gas analyzer for monitoring and controlling pollutant emissions from oil-fired boilers comprises a flue gas probe and a control output
01/26/2006DE10393660T5 Verfahren zur Identifizierung von Protein-CAMs (konstitutiv aktive Mutanten) A method of identifying protein CAMs (constitutively active mutants)
01/26/2006DE10209427B4 Probengefäß zur Analyse von Schmelzen Sample vial for analysis of melts
01/26/2006DE102005021001A1 Bildbasiertes Verfahren zum Detektieren und Entfernen von kleinen Fragmenten in segmentierten dreidimensionalen Volumina Image-based method for detecting and removing small fragments in segmented three-dimensional volumes
01/26/2006DE102004033586A1 Verfahren zur Auswertung von Biochips A method for evaluation of biochips
01/26/2006DE102004031639A1 Through-flow measuring device for operating a gas analysis unit suctions the measuring gas through an analyzer and a capillary
01/26/2006DE10112485B4 Gerät zur Analyse von Gasen und Gasgemischen Device for the analysis of gases and gas mixtures
01/26/2006CA2612303A1 Anti-glycated cd59 antibodies and uses thereof
01/26/2006CA2600899A1 Microfluidic device and method of using same
01/26/2006CA2575404A1 Active substances for increasing pathogenic defence in plants and methods for the detection thereof
01/26/2006CA2574634A1 Apparatus components and methods of using apparatus components to detect the presence of an analyte
01/26/2006CA2574530A1 Cell cycle phase markers comprising phosphorylated subcellular localization domain (psld) of human dna helicase b (hdhb)
01/26/2006CA2574224A1 Molecular diagnostic method and treatment in dementia with lewy bodies
01/26/2006CA2574196A1 Use of haptoglobin and hemoglobin to modulate na ion transport in a vertebrate
01/26/2006CA2574177A1 Lrp4/corin dopaminergic neuron progenitor cell markers
01/26/2006CA2574146A1 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
01/26/2006CA2573926A1 System and method for rapid reading of macro and micro matrices
01/26/2006CA2573710A1 Electrochemical sensor for in-vivo or ex-vivio measurements of the carbon dioxide partial pressure of living tissue
01/26/2006CA2573357A1 Methods and assays for detecting guanylate cyclase activity
01/26/2006CA2573112A1 Methods and compositions for the detection of ovarian cancer
01/26/2006CA2572558A1 Methods of treating neurological conditions with hematopoeitic growth factors
01/26/2006CA2571540A1 Methods for measuring chloride channel conductivity
01/26/2006CA2571250A1 Galnts as modifiers of the igfr pathway and methods of use
01/26/2006CA2570501A1 Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
01/26/2006CA2570422A1 Methods for identifying stem cells based on nuclear morphotypes
01/26/2006CA2570168A1 Dispenser for flattened articles
01/26/2006CA2569191A1 C-met kinase binding proteins
01/26/2006CA2568012A1 Cdk9 as modifier of the igf pathway and methods of use
01/26/2006CA2567982A1 P4has as modifiers of the igfr pathway and methods of use
01/25/2006EP1619538A1 Method of selecting contact lens and/or care system therefor
01/25/2006EP1619505A2 Method for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
01/25/2006EP1619504A1 Novel use of the kinases RSK4 and PAK5
01/25/2006EP1619503A1 Use of standards for monitoring alterations of peptide and protein samples
01/25/2006EP1619502A1 Fecal occult blood testing device and method
01/25/2006EP1619501A1 Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
01/25/2006EP1619500A1 Biochip and biochip kit, and method of producing the same and method of using the same
01/25/2006EP1619499A1 Novel screening method
01/25/2006EP1619498A2 Method of screening remedy for heart disease and medicinal composition for treating heart disease
01/25/2006EP1619496A1 Apparatus and method for measuring biological material
01/25/2006EP1619259A2 Sequencing method using magnifying tags
01/25/2006EP1619251A1 A mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapy
01/25/2006EP1619250A1 WSX receptor and ligands
01/25/2006EP1619246A1 RNA dependent RNA polymerases from coronavirus and their use in molecular biology and drug screening
01/25/2006EP1619208A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein
01/25/2006EP1619206A2 Tissue inhibitor of matrix metallproteinases type-1 (TIMP-1) as a cancer marker
01/25/2006EP1619205A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
01/25/2006EP1619130A1 Liquid storage container and cartridge
01/25/2006EP1618957A2 Fecal sampling device and method
01/25/2006EP1618955A1 Biological molecules detection device having increased detection rate, and method for quick detection of biological molecules
01/25/2006EP1618939A1 Liquid filtering instrument and dry type analysis device
01/25/2006EP1618899A2 Method of measuring physiological function
01/25/2006EP1618888A1 Production of human papillomavirus capsid protein and virus-like particles
01/25/2006EP1618388A2 Proteomic analysis of biological fluids
01/25/2006EP1618387A1 Screening method for identifying hsp90 modulators
01/25/2006EP1618386A2 Methods and means for the treatment of disorders associated with cellular senescence
01/25/2006EP1618385A2 Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
01/25/2006EP1618384A2 Methods utilising g-protein coupled receptor 54
01/25/2006EP1618383A1 Membrane strip biosensor system for point-of-care testing
01/25/2006EP1618382A1 Improved composite microarry slides